GENEVA, July 1 -- CARDURION PHARMACEUTICALS, INC. filed a patent application (US2024/043375) for “PYRAZOLO[3,4-D]PYRIMIDINONE COMPOUNDS FOR THE TREATMENT OF CHRONIC HEART FAILURE”. With publication no. WO/2025/043067, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: C07D 487/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....